A peptide mimetic of human interferon (IFN)-β

Biochemical Journal

Volumn 371, Issue 2, 2003, Pages 603-608

  Sato, Atsushi ^a,b   Sone, Saburo ^a  

^a TORAY INDUSTRIES INC   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Cytokine; Heterodimeric receptor; Interferon; Mimetic; Neutralizing monoclonal antibody; Phage display

Indexed keywords

ANTIBODIES; CONTAMINATION; DIMERS; HUMAN ENGINEERING;

CYTOKINES;

PROTEINS;

BETA INTERFERON; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN G1; INTERFERON RECEPTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; BINDING SITES; HUMANS; INTERFERON-BETA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RECOMBINANT PROTEINS;

EID: 0037964430     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020993     Document Type: Article

References (29)

1. Tyring, S. K. (1995) Interferons: biochemistry and mechanisms of action. Am. J. Obstet. Gynecol. 172, 1350-1353
2. Hoofnagle, J. H. (1998) Therapy of viral hepatitis. Digestion 59, 563-578
3. Taniguchi, T., Mantei, N., Schwarzstein, M., Nagata, S., Muramatsu, M. and Weissmann, C. (1980) Human leukocyte and fibroblast interferons are structurally related. Nature (London) 285, 547-549
4. Mogensen, K. E., Lewerenz, M., Reboul, J., Lutfalla, G. and Uzé, G. (1999) The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19, 1069-1098
5. Schindler, C. and Darnell, J. J. (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64, 621-651
6. Sedmak, J. J., Jameson, P. and Grossberg, S. E. (1981) Procedures for stabilization of interferons. Methods Enzymol. 78, 591-595
7. Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K. and Dower, W. J. (1996) Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-464
8. Tian, S. S., Lamb, P., King, A. G., Miller, S. G., Kessler, L., Luengo, J. I., Averill, L., Johnson, R. K., Gleason, J. G., Pelus, L. M. et al. (1998) A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science 281, 257-259
9. Cwirla, S. E., Balasubramanian, P., Duffin, D. J., Wagstrom, C. R., Gates, C. M., Singer, S. C., Davis, A. M., Tansik, R. L., Mattheakis, L. C., Boytos, C. M. et al. (1997) Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 276, 1696-1699
10. Kimura, T., Kaburaki, H., Miyamoto, S., Katayama, J. and Watanabe, Y. (1997) Discovery of a novel thrombopoietin mimic agonist peptide. J. Biochem. (Tokyo) 122, 1046-1051
11. Kimura, T., Kaburaki, H., Tsujino, T., Ikeda, Y., Kato, H. and Watanabe, Y. (1998) A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl. FEBS Lett. 428, 250-254
12. Ballinger, M. D., Shyamala, V., Forrest, L. D., Deuter, R. M., Doyle, L. V., Wang, J. X., Panganiban, L. L., Stratton, J. R., Apell, G., Winter, J. A. et al. (1999) Semirational design of a potent, artificial agonist of fibroblast growth factor receptors. Nat. Biotechnol. 17, 1199-1204
13. Zhang, B., Salituro, G., Szalkowski, D., Li, Z., Zhang, Y., Royo, I., Vilella, D., Diez, M. T., Pelaez, F., Ruby, C. et al. (1999) Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284, 974-977
14. Whitty, A. and Borysenko, C. W. (1999) Small molecule cytokine mimetics. Chem. Biol. 6, R107-R118
15. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103, 211-225
16. Smith, G. P. (1997) Phage display. Chem. Rev. 97, 391-410
17. Yamazaki, S., Kuramoto, K., Matsuo, E., Hosoi, K., Hara, M. and Shimizu, H. (1989) Highly sensitive enzyme immunoassay of human interferon-β 1. J. Immunoassay 10, 57-73
18. Sato, A., Ida, N., Fukuyama, M., Miwa, K., Kazami, J. and Nakamura, H. (1996) Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules. Biochemistry 35, 10441-10447
19. Sato, A., Yamamoto, S., Ishihara, K., Hirano, T. and Jingami, H. (1999) Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157). Biochem. J. 337, 491-496
20. Armstrong, J. A. (1981) Cytopathic effect inhibition assay for interferon: microculture plate assay. Methods Enzymol. 78, 381-387
21. Sugi, M., Kato, H., Fujimoto, M., Utsumi, J., Hosoi, K., Shimizu, H. and Kobayashi, S. (1987) Monoclonal antibody to human β interferon: characterization and application. Hybridoma 6, 313-320
22. Piehler, J. and Schreiber, G. (1999) Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNα2. J. Mol. Biol. 289, 57-67
23. Binetruy, T. R., Demangel, C., Malavaud, B., Vassy, R., Rouyre, S., Kraemer, M., Plouet, J., Derbin, C., Perret, G. and Mazie, J. C. (2000) Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 19, 1525-1533
24. Fukumoto, T., Torigoe, N., Kawabata, S., Murakami, M., Uede, T., Nishi, T., Ito, Y. and Sugimura, K. (1998) Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation. Nat. Biotechnol. 16, 267-270
25. Yayon, A., Aviezer, D., Safran, M., Gross, J. L., Heldman, Y., Cabilly, S., Givol, D. and Katchalski, K. E. (1993) Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl Acad. Sci. U.S.A. 90, 10643-10647
26. Domanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P. and Colamonici, O. R. (1995) Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signaling. J. Biol. Chem. 270, 21606-21611
27. Special topics issue, Oral Use of Interferons and Cytokines (1999) J. Interferon Cytokine Res. 19, 813-978
28. Satoh, Y., Kasama, K., Kuwabara, M., Yimin, Diao, H. Y., Nakajima, H., Kohanawa, M. and Minagawa, T. (1999) Suppression of late asthmatic response by low-dose oral administration of interferon-β in the guinea pig model of asthma. J. Interferon Cytokine Res. 19, 887-894
29. Kallen, K. J., Grotzinger, J. and Rose-John, S. (2000) New perspectives on the design of cytokines and growth factors. Trends Biotechnol. 18, 455-461